|
|
 Previous Article | Table of Contents | Next Article 
Cross-linking of the beta-glucan receptor on human monocytes results in
interleukin-1 receptor antagonist but not interleukin-1 production
DD Poutsiaka, M Mengozzi, E Vannier, B Sinha and CA Dinarello
Department of Medicine, New England Medical Center, Boston, MA 02111.
The beta-glucan receptor, found on monocytes and neutrophils, binds glucose
polymers derived from fungi. Ligands for the receptor have various
immunomodulatory effects, including increased microbicidal killing
activity. We have investigated the effect of beta-glucans on the production
of interleukin-1 (IL-1) and its naturally occurring inhibitor, the IL-1
receptor antagonist (IL-1Ra). Particulate beta- glucan induced IL-1Ra
production from human peripheral blood mononuclear cells (PBMC) but did not
stimulate IL-1 beta synthesis or gene expression in these same cells.
Monomeric (soluble) beta-glucan did not induce IL-1Ra production. However,
when preincubated with PBMC, monomeric beta-glucan significantly (P <
.01) reduced particulate beta- glucan induction of IL-1Ra by 40%,
suggesting that crosslinking of beta- glucan receptors is required for
induction of IL-1Ra. In support of this, monomeric beta-glucan immobilized
on plastic surfaces stimulated IL-1Ra production. Vitamin D3, which
increases the functional capacity of beta-glucan receptors, increased
IL-1Ra production induced by particulate beta-glucan, whereas dexamethasone
suppressed IL-1Ra synthesis. Because of their differential effects on
cytokine production, beta-glucans may be used to therapeutic advantage in
the diseases in which IL-1 is implicated.
Volume 82,
Issue 12,
pp. 3695-3700,
12/15/1993
Copyright © 1993 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
R. Kikkert, I. Bulder, E. R. de Groot, L. A. Aarden, and M. A. Finkelman
Potentiation of Toll-like receptor-induced cytokine production by (1->3)-{beta}-D-glucans: implications for the monocyte activation test
Innate Immunity,
June 1, 2007;
13(3):
140 - 149.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. Li, D. F. Li, J. J. Xing, Z. B. Cheng, and C. H. Lai
Effects of {beta}-glucan extracted from Saccharomyces cerevisiae on growth performance, and immunological and somatotropic responses of pigs challenged with Escherichia coli lipopolysaccharide
J Anim Sci,
September 1, 2006;
84(9):
2374 - 2381.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. F. Mao, X. S. Piao, C. H. Lai, D. F. Li, J. J. Xing, and B. L. Shi
Effects of {beta}-glucan obtained from the Chinese herb Astragalus membranaceus and lipopolysaccharide challenge on performance, immunological, adrenal, and somatotropic responses of weanling pigs
J Anim Sci,
December 1, 2005;
83(12):
2775 - 2782.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Friedland, D. Constantin, T. C. Shaw, and E. Stylianou
Regulation of interleukin-8 gene expression after phagocytosis of zymosan by human monocytic cells
J. Leukoc. Biol.,
September 1, 2001;
70(3):
447 - 454.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. P. Dellinger, T. J. Babineau, P. Bleicher, A. B. Kaiser, G. B. Seibert, R. G. Postier, S. B. Vogel, J. Norman, D. Kaufman, S. Galandiuk, et al.
Effect of PGG-glucan on the Rate of Serious Postoperative Infection or Death Observed After High-Risk Gastrointestinal Operations
Arch Surg,
September 1, 1999;
134(9):
977 - 983.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Soltys and M. T. Quinn
Modulation of Endotoxin- and Enterotoxin-Induced Cytokine Release by In Vivo Treatment with beta -(1,6)-Branched beta -(1,3)-Glucan
Infect. Immun.,
January 1, 1999;
67(1):
244 - 252.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Kernodle, H. Gates, and A. B. Kaiser
Prophylactic Anti-Infective Activity of Poly-[1-6]-beta -D-Glucopyranosyl-[1-3]-beta -D-Glucopyranose Glucan in a Guinea Pig Model of Staphylococcal Wound Infection
Antimicrob. Agents Chemother.,
March 1, 1998;
42(3):
545 - 549.
[Abstract]
[Full Text]
|
|
|
|
|
